Cargando…

Association between low estrogen receptor positive breast cancer and staining performance

Estrogen receptor (ER) expression in breast carcinomas, determined by immunohistochemistry, indicates statistically significant benefit to endocrine therapy in patients with tumors expressing ER in ≥1% of tumor cells. Rare cases with low ER expression (1–10%) lead to the dilemma of treating these tu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caruana, Dennis, Wei, Wei, Martinez-Morilla, Sandra, Rimm, David L., Reisenbichler, Emily S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002746/ https://www.ncbi.nlm.nih.gov/pubmed/32047851 http://dx.doi.org/10.1038/s41523-020-0146-2

Ejemplares similares

Immunological Differences Between Immune-Rich Estrogen Receptor–Positive and Immune-Rich Triple-Negative Breast Cancers
por: O’Meara, Tess, et al.
Publicado: (2020)

Characteristics and Prognosis of Estrogen Receptor Low-Positive Breast Cancer
por: Kim, Min Chong, et al.
Publicado: (2022)

Estrogen-Receptor-Low-Positive Breast Cancer: Pathological and Clinical Perspectives
por: Malainou, Christina Panagiotis, et al.
Publicado: (2023)

Immunohistochemical Performance of Estrogen and Progesterone Receptor Antibodies on the Dako Omnis Staining Platform: Evaluation in Multicenter Studies
por: Hicks, David, et al.
Publicado: (2017)

Expression of Androgen Receptor in Estrogen Receptor–positive Breast Cancer
por: Agrawal, Anil, et al.
Publicado: (2016)

The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer
por: Allred, D Craig, et al.
Publicado: (2004)

Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer
por: Datta, Jharna, et al.
Publicado: (2022)

Clinical characteristics and survival outcome of patients with estrogen receptor low positive breast cancer
por: Luo, Chuanxu, et al.
Publicado: (2022)

Standardization of PD-L1 immunohistochemistry
por: Martinez-Morilla, Sandra, et al.
Publicado: (2021)

Mouse models of estrogen receptor-positive breast cancer
por: Mohibi, Shakur, et al.
Publicado: (2011)

Positive Regulation of Estrogen Receptor Alpha in Breast Tumorigenesis
por: Porras, Lucas, et al.
Publicado: (2021)

Technique and Feasibility of a Dual Staining Method for Estrogen Receptors and AgNORs
por: Günther, Lukas, et al.
Publicado: (2000)

Correlating nuclear morphometric patterns with estrogen receptor status in breast cancer pathologic specimens
por: Rawat, Rishi R., et al.
Publicado: (2018)

Genes Dysregulated to Different Extent or Oppositely in Estrogen Receptor-Positive and Estrogen Receptor-Negative Breast Cancers
por: Zhou, Xianxiao, et al.
Publicado: (2013)

Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers
por: Chiu, Jen-Hwey, et al.
Publicado: (2017)

Estrogen receptor α is involved in the regulation of ITGA8 methylation in estrogen receptor-positive breast cancer
por: Wu, Jingxun, et al.
Publicado: (2020)

Outcomes of Estrogen Receptor Negative and Progesterone Receptor Positive Breast Cancer
por: Chan, Melissa, et al.
Publicado: (2015)

Deep learning trained on hematoxylin and eosin tumor region of Interest predicts HER2 status and trastuzumab treatment response in HER2+ breast cancer
por: Farahmand, Saman, et al.
Publicado: (2022)

Study of Estrogen Receptor and Progesterone Receptor Expression in Breast Ductal Carcinoma In Situ by Immunohistochemical Staining in ER/PgR-Negative Invasive Breast Cancer
por: Dobrescu, Andrei, et al.
Publicado: (2011)

Survival Benefit of Tamoxifen in Estrogen Receptor-Negative and Progesterone Receptor-Positive Low Grade Breast Cancer Patients
por: Yang, Li-Heng, et al.
Publicado: (2012)

Targeting the cyclin-dependent kinases (CDK) 4/6 in estrogen receptor-positive breast cancers
por: Finn, Richard S., et al.
Publicado: (2016)

Estrogen receptor-β: why may it influence clinical outcome in estrogen receptor-α positive breast cancer?
por: Shupnik, Margaret A
Publicado: (2007)

Estrogen receptor coregulator binding modulators (ERXs) effectively target estrogen receptor positive human breast cancers
por: Raj, Ganesh V, et al.
Publicado: (2017)

Estrogen Receptor Bio-Activities Determine Clinical Endocrine Treatment Options in Estrogen Receptor-Positive Breast Cancer
por: Xia, Song, et al.
Publicado: (2022)

Quantification of angiogenesis in estrogen receptor-positive and negative breast carcinoma
por: Parentes-Vieira, JB, et al.
Publicado: (2007)

Estrogen receptor positive breast cancers and their association with environmental factors
por: St-Hilaire, Sophie, et al.
Publicado: (2011)

Collaborative Management of Patients With Estrogen Receptor–Positive Breast Cancer
por: Schwartzberg, Lee S., et al.
Publicado: (2017)

Upregulation of HSF1 in estrogen receptor positive breast cancer
por: Gökmen-Polar, Yesim, et al.
Publicado: (2016)

Estrogen receptor-positive primary squamous cell carcinoma of the breast
por: Pribish, Abby M., et al.
Publicado: (2017)

The impact of CBP expression in estrogen receptor-positive breast cancer
por: Ramadan, Wafaa S., et al.
Publicado: (2021)

A Novel Dual Antibody Staining Assay to Measure Estrogen Receptor Transcriptional Activity
por: van Hemert, Freek, et al.
Publicado: (2020)

The impact of endogenous estrogen exposures on the characteristics and outcomes of estrogen receptor positive, early breast cancer
por: Korzets, Yasmin, et al.
Publicado: (2021)

Schisandrol A Exhibits Estrogenic Activity via Estrogen Receptor α-Dependent Signaling Pathway in Estrogen Receptor-Positive Breast Cancer Cells
por: Lee, Dahae, et al.
Publicado: (2021)

Automated measurement of estrogen receptor in breast cancer: a comparison of fluorescent and chromogenic methods of measurement
por: Zarrella, Elizabeth, et al.
Publicado: (2016)

Low expression of a few genes indicates good prognosis in estrogen receptor positive breast cancer
por: Buechler, Steven
Publicado: (2009)

De‐escalation of five‐year adjuvant endocrine therapy in patients with estrogen receptor‐low positive (immunohistochemistry staining 1%‐10%) breast cancer: Propensity‐matched analysis from a prospectively maintained cohort
por: Cai, Yu‐Wen, et al.
Publicado: (2022)

mRNA expression profiles show differential regulatory effects of microRNAs between estrogen receptor-positive and estrogen receptor-negative breast cancer
por: Cheng, Chao, et al.
Publicado: (2009)

Estrogen Receptor- And Progesterone Receptor-Positive Thresholds in Predicting the Recurrence of Early Low-Risk Endometrial Cancer
por: Li, Ning, et al.
Publicado: (2022)

Autocrine regulation of cell proliferation by estrogen receptor-alpha in estrogen receptor-alpha-positive breast cancer cell lines
por: Tan, Huining, et al.
Publicado: (2009)

Estrogen receptor splice variants as a potential source of false-positive estrogen receptor status in breast cancer diagnostics
por: Groenendijk, Floris H., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_k9ok18h67v7j59qo0uedmokd6a